Because of increasing scientific research on lupus, significant advances are being made. This proves the point made here, in "Lupus Awareness Month", just down this page. If we want to contribute to lupus research, we can accomplish more through direct donations. Not everyone who claims to support our cause is actually supporting our true interests. Some people are just in it for the money - we're in it for life.
"Thanks to a newly identified gatekeeper gene, lupus is now a preventable disease for mice. Humans could be next." The RU Scientist at Rockefeller University. Lupus illuminated
By Lynn Love.
"In the treatment of severe lupus nephritis, mycophenolate mofetil has emerged as an alternative to cyclophosphamide, offering a major advance in the therapy of lupus nephritis." JAMA Vol. 293 No. 24, June 22/29, 2005 Pharmacological Therapy of Lupus Nephritis
Derek M. Fine, MD - JAMA. 2005;293:3053-3060.
Not all research is good for us or for our children. Without an ethical rudder and a moral compass, good intentions can be devoured by sharks in the water. EPA rule loopholes allow pesticide testing on kids
By Andrew Schneider, Baltimore Sun September 15, 2005 and reprinted by the San Francisco Chronicle.
There are some very interesting articles listed at the pages linked below. Please take a good look - you may find something that relates to your circumstances or those of someone you love. Most Viewed Health News on Yahoo! News The top health news articles from Yahoo! News
These next two links were contributed by an LNL reader who wrote "The first is on the disability process for lupus patients. The second is a good alternative med page for lupus.". I'd like to give due credit for the aid but didn't get a name. I'm very glad for the contribution and appreciate the consideration. As I've written before, this work and this site are of, for and by lupies, for the benefit of us all. APPLYING FOR BENEFITS WITH LUPUS
from Disability Secrets.com Alternative Medicine and Lupus, Part 1
Vitamin Stuff .com. There's a link there, at the end of the article, that leads to its Part 2.